Nutrien delivered a solid operational quarter with record potash volumes and strong free cash flow generation. The raised potash volume guidance and lowered capex are incremental positives, while the phosphate margin compression is a known headwind.
How the stock moved after the report
BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 6 $66.76entry
- T+1 · 3mo ago −3.51%α −4.12% · $64.42
- T+5 · 3mo ago +1.06%α −0.15% · $67.47
- T+20 · 3mo ago +20.93%α +20.33% · $80.73
- T+60 · 18d ago +3.98%α +5.66% · $69.42
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Nutrien reported Q2 2026 net earnings of $1.22B ($2.53 diluted EPS) on revenue of $10.81B, with adjusted EBITDA of $2.43B and adjusted EPS of $2.61. First-half results showed record potash sales volumes, strong proprietary products margins, and 12% operating cash flow growth. Guidance was modestly updated: potash volume guidance raised to 14.2-14.8M tonnes and capital expenditure guidance lowered to $1.95-2.05B, while other metrics were unchanged. Q2 comparisons showed slight net earnings decline (-1%) and adjusted EBITDA decline (-2%) YoY as higher fertilizer benchmarks were offset by lower volumes and higher sulfur costs, but the stronger first-half trajectory and increased shareholder returns ($848M returned in H1, up 8% YoY) provide a generally positive read.
Key Facts
- Q2 2026 revenue: $10.81B (+4% YoY); Q2 net earnings: $1.22B (-1% YoY); Q2 adjusted EBITDA: $2.43B (-2% YoY)
- Q2 diluted EPS: $2.53 (+1% YoY); Q2 adjusted EPS: $2.61 (-2% YoY)
- First-half 2026 revenue: $16.86B (+8% YoY); H1 net earnings: $1.36B (+9% YoY); H1 adjusted EBITDA: $3.54B (+6% YoY)
- H1 diluted EPS: $2.80 (+11% YoY); H1 adjusted EPS: $3.11 (+13% YoY)
- Potash: H1 adjusted EBITDA $1.24B (+15% YoY) on record first-half sales volumes (7.45M tonnes) and higher global benchmarks
- Nitrogen: H1 adjusted EBITDA $1.12B (+4% YoY) driven by higher benchmarks and lower natural gas costs
- Retail: H1 adjusted EBITDA $1.24B (+4% YoY) on higher proprietary products margins and strong Australia livestock market
- Phosphate: Q2 adjusted EBITDA collapsed 75% to $23M; H1 down 48% to $80M on elevated sulfur input costs
- Guidance: Potash sales volumes raised to 14.2-14.8M tonnes (from 14.1-14.8M); capex lowered to $1.95-2.05B (from $2.0-2.1B); Retail adjusted EBITDA guidance unchanged at $1.75-1.95B
- Cash provided by operating activities H1: $1.63B (+12% YoY); returned $848M to shareholders via dividends and buybacks (+8% YoY)
- Since June 2026, entered agreements to sell non-core assets for ~$90M; ~$1B divested since Q4 2024
Financial Impact
Nutrien's Q2 results were slightly below Q2 2025 on the top-line comparable but H1 shows solid 6-13% growth in adjusted EBITDA/EPS. The raised potash guidance and lowered capex are incrementally positive. The phosphate business remains a drag, but overall the company is generating strong free cash flow and returning more to shareholders.
Risk Factors
- Continued phosphate margin compression due to elevated sulfur costs and constrained feedstock availability
- Geopolitical uncertainty and trade flow disruptions impacting nitrogen and potash benchmark prices
- Lower Q2 nitrogen volumes due to plant shutdowns (Trinidad, New Madrid) and deferred customer purchases
- Sensitivity to global crop prices and grower affordability, particularly in Brazil
- Higher restructuring costs ($82M in H1 vs $22M in H1 2025) tied to portfolio optimization
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001193125-26-335517 |
| Document: d129364dex993.htm | 0001193125-26-335517 |
| Document: d129364dex992.htm | 0001193125-26-335517 |
| Document: d129364d6k.htm | 0001193125-26-335517 |
| Document: 0001193125-26-335517-index-headers.html | 0001193125-26-335517 |
| Document: 0001193125-26-335517-index.html | 0001193125-26-335517 |
| Document: 0001193125-26-335517.txt | 0001193125-26-335517 |
Track record
9 reports on NTR
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 4, 202612d ago 6-K Neutral 2/10 Entry $72.21 to $71.22 Now $68.94 −4.53% ▼ −1.37% −4.66% vs SPY
- Nov 4, 202612d ago 6-K Bearish 6/10 Entry $72.21 to $71.22 Now $68.94 +4.53% ▲ +1.37% +4.66% vs SPY
- Oct 26, 202621d ago Institutional Cluster Neutral 3/10 Entry $68.22 to $69.42 Now $68.94 +1.06% ▲ +1.76% +3.02% vs SPY
- Oct 5, 20266w ago 6-K Neutral 4/10 Entry $70.26 to $68.00 Now $68.94 −1.88% ▼ −3.22% −3.64% vs SPY
- Aug 5, 202614w ago 6-K Bullish 6/10 Viewing Entry $66.76 to $67.47 Now $68.94 +3.27% ▲ +1.06% −0.15% vs SPY
- May 29, 202624w ago 6-K Neutral 4/10 Entry $69.57 to $67.20 Now $68.94 −0.91% ▼ −3.41% −0.66% vs SPY
- May 27, 202624w ago 6-K Neutral 3/10 Entry $69.65 to $68.81 Now $68.94 −1.02% ▼ −1.21% −1.16% vs SPY
- May 6, 202627w ago 6-K Neutral 2/10 Entry $68.38 to $71.29 Now $68.94 +0.82% ▲ +4.26% +2.75% vs SPY
- Mar 30, 202633w ago Court Ruling Neutral 3/10 Entry $76.00 to $76.88 Now $68.94 −9.29% ▲ +1.16% −3.14% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers